Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEDI-PHYSICS WILL MARKET SUMMA MEDICAL BLOOD CLOT IMAGING AGENT

Executive Summary

MEDI-PHYSICS WILL MARKET SUMMA MEDICAL BLOOD CLOT IMAGING AGENT under a licensing agreement announced Oct. 15. Roche's Medi-Physics subsidiary will have exclusive worldwide rights to Summa's Summa-Clot monoclonal antibody-based in vivo diagnostic and "will pay Summa an undisclosed amount of cash and a royalty on all adjusted gross sales in the United States and abroad," Summa said. Summa will conduct clinical trials of the blood clot diagnostic at the University of Oklahoma under an IND. The in vivo diagnostic agent is being investigated for use in blood clot-related disorders such as heart attacks, strokes and other forms of thrombosis and embolism. Summa said it expects Medi-Physics to conduct additional clinical trials. In a related matter, Summa announced Oct. 1 that it entered into an agreement with Medi-Physics, giving the Hoffmann-LaRoche division an option to purchase the assets of Summa's radiopharmacy business for approximately $7 mil. The transaction covers 10 Summa-owned pharmacies in Chicato, New Orleans, Seattle, and Washington, D.C., with the remainder in California. The option term expires on Nov. 15
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS012668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel